Mario Sznol, MD

Internal Medicine, Medical Oncology

Vion Pharmaceuticals

NORTH MIAMI, FL

QC-verified· April 2026 PI on 6 trialsNPI: 1073501748

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Acute myeloid leukemia with 11q23 abnormalities
Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement
Adult T-cell leukemia/lymphoma

Clinical trials (6)

NCT00025129
NCT00049686
NCT00049699
NCT00064090
NCT00070538
NCT00217542

Verify independently

ClinicalTrials.gov PI search for Mario Sznol
NPPES NPI registry entry

Other specialists for Acute myeloid leukemia with 11q23 abnormalities

Peers ranked by clinical-trial PI role, publications, and verification quality.

Soheil Meshinchi, MD, MD,PhD
Fred Hutchinson Cancer Center
WA
Bonny L. Johnson, RN, MSN
Vion Pharmaceuticals
B. Smith, M.S.W., L.C.S.W
Johns Hopkins University
OK
Leona Holmberg
Fred Hutch/University of Washington Cancer Consortium
WA
Bart Scott
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
WA
Guido Marcucci, M.D
Ohio State University
CA
Thomas G. Martin, MD
University of California, San Francisco
Colleen Delaney, MD
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
CT

See all specialists for Acute myeloid leukemia with 11q23 abnormalities →

← Back to specialists directory